Benedikt von Braunmuehl, newly-appointed CEO at Rentschler Biopharma

Rentschler names Benedikt von Braun­muehl as CEO; Catal­ent grabs David McEr­lane from Lon­za as bi­o­log­ics lead

Benedikt von Braun­muehl has been re­vealed as Rentschler Bio­phar­ma’s new CEO. Mean­while, Catal­ent al­so an­nounced that David …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.